Diseases, Conditions, Syndromes

New hope for patients with hereditary metabolic disease

Methylmalonic aciduria (MMA) is a metabolic disorder that affects approximately one in 90,000 newborns; both parents must carry a genetic predisposition to the disease. This means the disease is rare. The consequences are ...

Psychology & Psychiatry

From heroin addiction to alcohol-related problems

Around 3,000 heroin addicts currently receive opioids such as methadone, buprenorphine or morphine as part of their treatment in the Canton of Zurich. The number of these so-called substitution treatments has remained constant ...

Addiction

Wastewater reveals drug consumption picture

In 2013, wastewater samples from European cities were tested for drug traces for the third time. Basel, Berne, Geneva, St. Gallen and Zurich were among the 42 cities which took part in the study. Over the course of a week, ...

Health

Swiss building provides refuge for the hypersensitive

No smoking, no perfume, no mobile phone useā€”the list of rules at a newly opened apartment building on the outskirts of Zurich is long. For a reason: the structure has been purpose built for people who say exposure to everyday ...

Health

Child sexual abuse via the Internet on the rise

Sexual abuse of children and adolescents can have serious health consequences for victims. Early studies have revealed that child sexual abuse is associated with an increased risk of later mental and physical health problems ...

Other

EU court finds Swiss assisted-suicide laws vague (Update)

An elderly Swiss woman who would rather end her life now than decline further in health found sympathy Tuesday from the European Court of Human Rights, which called on the Swiss to clarify their laws on so-called passive ...

Oncology & Cancer

EU approves skin cancer fighting drug: Roche

Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.

Other

Novartis announces 2,000 job losses, profits up

Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.

page 1 from 2